BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 10709674)

  • 1. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs.
    Pereira MA
    Adv Exp Med Biol; 1999; 470():55-63. PubMed ID: 10709674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci.
    Zheng Y; Kramer PM; Lubet RA; Steele VE; Kelloff GJ; Pereira MA
    Carcinogenesis; 1999 Feb; 20(2):255-60. PubMed ID: 10069462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats.
    Zheng Y; Kramer PM; Olson G; Lubet RA; Steele VE; Kelloff GJ; Pereira MA
    Carcinogenesis; 1997 Nov; 18(11):2119-25. PubMed ID: 9395211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.
    Wargovich MJ; Jimenez A; McKee K; Steele VE; Velasco M; Woods J; Price R; Gray K; Kelloff GJ
    Carcinogenesis; 2000 Jun; 21(6):1149-55. PubMed ID: 10837003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon.
    Li H; Schut HA; Conran P; Kramer PM; Lubet RA; Steele VE; Hawk EE; Kelloff GJ; Pereira MA
    Carcinogenesis; 1999 Mar; 20(3):425-30. PubMed ID: 10190557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regressive effects of various chemopreventive agents on azoxymethane-induced aberrant crypt foci in the rat colon.
    Morishita Y; Yoshimi N; Kawabata K; Matsunaga K; Sugie S; Tanaka T; Mori H
    Jpn J Cancer Res; 1997 Sep; 88(9):815-20. PubMed ID: 9369928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in rats.
    Li H; Kramer PM; Lubet RA; Steele VE; Kelloff GJ; Pereira MA
    Cancer Lett; 1999 Dec; 147(1-2):187-93. PubMed ID: 10660105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents.
    Pereira MA; Barnes LH; Rassman VL; Kelloff GV; Steele VE
    Carcinogenesis; 1994 May; 15(5):1049-54. PubMed ID: 8200067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 2-(carboxyphenyl) retinamide and genistein on the formation of early lesions in 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.
    Zhi H; Yamada Y; Hirose Y; Kato K; Sheng H; Zheng Q; Oyama T; Asano N; Kuno T; Hara A; Mori H
    Asian Pac J Cancer Prev; 2007; 8(1):33-8. PubMed ID: 17477768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats.
    Pereira MA; Barnes LH; Steele VE; Kelloff GV; Lubet RA
    Carcinogenesis; 1996 Feb; 17(2):373-6. PubMed ID: 8625466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of azoxymethane-induced colonic aberrant crypt foci by dietary exposure to a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone, in rats.
    Kawamori T; Tanaka T; Hirose Y; Satoh K; Hara A; Torihara M; Tamai Y; Yamahara J; Mori H
    Cancer Lett; 1995 Jun; 92(2):159-65. PubMed ID: 7600526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of colon cancer carcinogenesis by balsalazide: inhibition of azoxymethane-induced aberrant crypt formation in the rat colon and intestinal tumor formation in the B6-Min/+ mouse.
    MacGregor DJ; Kim YS; Sleisenger MH; Johnson LK
    Int J Oncol; 2000 Jul; 17(1):173-9. PubMed ID: 10853036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon.
    Wargovich MJ; Chen CD; Harris C; Yang E; Velasco M
    Int J Cancer; 1995 Feb; 60(4):515-9. PubMed ID: 7829266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of aberrant crypt foci by chemopreventive agents.
    Olivo S; Wargovich MJ
    In Vivo; 1998; 12(2):159-66. PubMed ID: 9627797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid.
    Kawamori T; Tanaka T; Kojima T; Suzui M; Ohnishi M; Mori H
    Jpn J Cancer Res; 1994 Jul; 85(7):686-91. PubMed ID: 8071110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
    Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
    Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
    Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.
    Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS
    Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.